Nyxoah SA Price to Sales Ratio 2021-2024 | NYXH
Historical PS ratio values for Nyxoah SA (NYXH) over the last 10 years. The current P/S ratio for Nyxoah SA as of February 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Nyxoah SA P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-02-21 | 10.35 | 56.26 | |
| 2024-09-30 | 9.55 | $0.18 | 51.93 |
| 2024-06-30 | 6.97 | $0.18 | 38.62 |
| 2024-03-31 | 13.49 | $0.20 | 68.94 |
| 2023-12-31 | 4.64 | $0.17 | 27.66 |
| 2023-09-30 | 7.05 | $0.15 | 47.29 |
| 2023-06-30 | 8.01 | $0.12 | 67.24 |
| 2023-03-31 | 7.47 | $0.12 | 64.73 |
| 2022-12-31 | 4.99 | $0.13 | 39.65 |
| 2022-09-30 | 6.30 | $0.07 | 84.76 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||